SCHEMBL7714596

SCHEMBL7714596

Nc1ncc(Oc2cccc(F)c2F)c(=O)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.42
TRPA1 O75762 1/20 0.42
TYMS P04818 2/20 0.38
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
HTR1A P08908 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
EGLN1 Q9GZT9 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
SLC6A3 Q01959 1/20 0.35
NOS1 P29475 1/20 0.34
BTK Q06187 2/20 0.33
DAO P14920 1/20 0.33
HCAR1 Q9BXC0 1/20 0.33
MAPT P10636 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202525 0.80 MAPK14 (0.45) TRPA1
SCHEMBL7712456 0.78 MEN1 (0.44) XDHTRPA1TYMSMEN1KMT2A
SCHEMBL7712418 0.77 SMN1; SMN2 (0.41) XDHTYMSSLC6A2SLC6A4MEN1
SCHEMBL7714251 0.77 HTT (0.50) SLC6A2SLC6A4SLC6A3RECQL
SCHEMBL7712415 0.77 ALDH1A1 (0.41) XDHTYMSSLC6A2SLC6A4KMT2A
SCHEMBL7712364 0.76 USP2 (0.45) SLC6A2SLC6A4HTR1AKMT2ASLC22A12
SCHEMBL5206393 0.75 MEN1 (0.39) TYMSSLC6A2SLC6A4MEN1KMT2A
SCHEMBL5204487 0.74 SOS1 (0.40) TRPA1TYMSSLC6A4KMT2ASLC22A12
SCHEMBL5206240 0.74 NOS1 (0.45) XDHNOS1RECQL
SCHEMBL27859496 0.72 SLC6A2 (0.50) TRPA1SLC6A2SLC6A4HTR1AEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed